Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.

Revenue projections:

Revenue projections for METROPOLIS
Revenue projections for METROPOLIS

METROPOLIS's revenue projections show a decrease from last year, which tends to make investors more cautious. This could have a negative impact on the company's bottom line, as lower revenues typically suggest reduced profitability and growth potential, prompting concern among investors.

Financial Ratios:

currentRatio 1.17500
forwardPE 42.79193
debtToEquity 15.29500
earningsGrowth -0.19700
revenueGrowth 0.04300
grossMargins 0.77241
operatingMargins 0.10135
trailingEps 28.20000
forwardEps 0.00000

METROPOLIS's current ratio of 1.175 shows that the company has ample resources to service its short-term debt. This indicates a solid financial position, as METROPOLIS can rely on its cash reserves and current assets to cover its immediate liabilities without strain.
Metropolis Healthcare Limited's low Debt-to-Equity ratio demonstrates that the company maintains a healthy balance between equity and debt, avoiding over-leverage. This suggests a low-risk financial profile, giving investors confidence in the company's stability and ability to manage its financial commitments.
METROPOLIS's low growth in both earnings and revenue indicates a likely decrease in profits. This suggests the company may be facing financial challenges, and investors should be cautious about its future performance.
METROPOLIS's negative gross and operating margins suggest that the company is currently losing money, unable to generate profit from production or operations. This could signal inefficiencies in cost control or a drop in sales.

Price projections:

Price projections for METROPOLIS
Price projections for METROPOLIS

METROPOLIS's price has consistently hovered around the lower limit of price projections. This pattern suggests that the stock may be underperforming relative to expectations, which could lead to concerns among investors.

Insider Transactions:

Insider Transactions for METROPOLIS
Insider Transactions for METROPOLIS


2 transactions to sell METROPOLIS occurred, with market price at 2095.9249267578125.No sell transactions were carried out during the period under review.More recent purchases than sales at current price levels for METROPOLIS could signal growing investor confidence. This buying trend might suggest that market sentiment is leaning toward a positive outlook for the stock, possibly indicating expectations of favorable performance in the near future.

Recommendation changes over time:

Recommendations trend for METROPOLIS
Recommendations trend for METROPOLIS


Recent analysis shows a strong buy bias for METROPOLIS, encouraging investors to view it as a solid investment option. The positive sentiment surrounding METROPOLIS suggests it could be an attractive place to allocate funds, motivating potential investors to consider the stock as a valuable part of their portfolio.